Mark L. Chiu

Integrated BioTherapeutics (United States)

MedicineBiochemistry, Genetics and Molecular Biology

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “GFR Estimation in Potential Living Kidney Donors: Race- and Nonrace-based Equations and Measured GFR”.

GFR Estimation in Potential Living Kidney Donors: Race- and Nonrace-based Equations and Measured GFR

Kidney Medicine(2022)10.1016/j.xkme.2022.100558

N/A

0DataRank · unranked

9 citations

Megan Chalupsky, Nasim Wiegley, Yihung Huang, Mark L. Chiu, Heejung Bang +4 more

Discovery and Phase 1 study of a novel monoclonal antibody against human IL-1β for the treatment of IL-1β-mediated diseases

Clinical & Experimental Immunology(2025)10.1093/cei/uxaf009

N/A

0DataRank · unranked

1 citations

Susan H. Tam, Lihua Shi, Isa Fung, Mark Tornetta, Gabriela Canziani +5 more